Lucchini et al., and Malmeström et al., further support the idea of CHI3L1 involvement in MS pathogenesis, as its elevated CSF levels were associated with a higher risk for relapse, higher activity of disease assessed by MRI, and increased disability progression in RRMS patients [76,107]. The gene discussed is CHI3L1; the disease is myeloid sarcoma.